RT Journal Article
SR Electronic
T1 Predictors of adverse outcome in patients with suspected COVID-19 managed in a ‘virtual hospital’ setting: a cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.09.20228189
DO 10.1101/2020.11.09.20228189
A1 Nick A Francis
A1 Beth Stuart
A1 Matthew Knight
A1 Rama Vancheeswaran
A1 Charles Oliver
A1 Merlin Willcox
A1 Andrew Barlow
A1 Michael Moore
YR 2020
UL http://medrxiv.org/content/early/2020/11/19/2020.11.09.20228189.abstract
AB Objective Identify predictors of adverse outcome in a Virtual Hospital (VH) setting for COVID 19.Design Real-world prospective observational study.Setting Virtual hospital remote assessment service in West Hertfordshire NHS Trust, UK.Participants Patients with suspected COVID-19 illness enrolled directly from the community (post-accident and emergency (A&E) or medical intake assessment) or post-inpatient admission.Main outcome measure Death or (re-)admission to inpatient hospital care over 28 days.Results 900 patients with a clinical diagnosis of COVID-19 (455 referred from A&E or medical intake and 445 post-inpatient) were included in the analysis. 76 (8.4%) of these experienced an adverse outcome (15 deaths in admitted patients, 3 deaths in patients not admitted, and 58 additional inpatient admissions). Predictors of adverse outcome were increase in age (OR 1.04 [95%CI: 1.02, 1.06] per year of age), history of cancer (OR 2.87 [95%CI: 1.41, 5.82]), history of mental health problems (OR 1.76 [95%CI: 1.02, 3.04]), severely impaired renal function (OR for eGFR <30 = 9.09 [95%CI: 2.01, 41.09]) and having a positive SARS-CoV-2 PCR result (OR 2.0 [95% CI: 1.11, 3.60]).Conclusions These predictors may help direct intensity of monitoring for patients with suspected or confirmed COVID-19 who are being remotely monitored by primary or secondary care services. Further research is needed to identify the reasons for increased risk of adverse outcome associated with cancer and mental health problems.Strengths and limitations of this studyThe study uses anonymised data from all patients registered for the virtual hospital between 17/03/20 and 17/05/20, and therefore selection bias is not an issue.At the time of this study, this was the only service providing remote follow-up for patients with suspected COVID-19 in the area, and therefore our findings are likely to be relevant to primary care patients receiving remote follow-up.We were able to collect reliable data on a wide range of clinical and demographic features, and reliably follow all patients for the primary outcome for at least two weeks following their discharge from the VH.We were not able to extract detailed symptom or clinical examination data, and there were significant amounts of missing data for some variables.Our study is likely underpowered to detect all predictors, especially in the analysis of our two sub-groupsCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialThis study uses medical record data and therefore was not registeredFunding StatementThis research received no specific grant funding from any funding agency in the public, commercial or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Regulatory and ethical approval for the study were provided by the Health Research Authority and Chelsea Research Ethics Committee (REC reference: 20/HRA/2342). The data used in this study were collected as part of routine healthcare during a pandemic. Participants did not provide consent to participate. Data were extracted from medical records by clinicians providing care for the patients and anonymised data were provided to the research team at the University of Southampton. No identifiable data left the hospital.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from West Hertfordshire Hospitals NHS Trust but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of West Hertfordshire Hospitals NHS Trust.